394248-90-9 Usage
Description
3-METHOXY-4-(2-PYRROLIDIN-1-YL-ETHOXY)-PHENYLAMINE, also known as MPPE, is a chemical compound with potential pharmaceutical applications. It is a derivative of phenethylamine and is structurally similar to the neurotransmitter serotonin. MPPE has been studied for its potential as a medication for various psychiatric and neurological disorders, including depression, anxiety, and schizophrenia. It acts as a selective serotonin and norepinephrine reuptake inhibitor, which could make it useful in treating mood disorders. However, further research is needed to fully understand the pharmacological properties and potential therapeutic uses of this compound.
Uses
Used in Pharmaceutical Industry:
3-METHOXY-4-(2-PYRROLIDIN-1-YL-ETHOXY)-PHENYLAMINE is used as a potential medication for various psychiatric and neurological disorders such as depression, anxiety, and schizophrenia. Its action as a selective serotonin and norepinephrine reuptake inhibitor makes it a promising candidate for treating mood disorders. Further research is required to explore its pharmacological properties and therapeutic potential fully.
Check Digit Verification of cas no
The CAS Registry Mumber 394248-90-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,9,4,2,4 and 8 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 394248-90:
(8*3)+(7*9)+(6*4)+(5*2)+(4*4)+(3*8)+(2*9)+(1*0)=179
179 % 10 = 9
So 394248-90-9 is a valid CAS Registry Number.
InChI:InChI=1/C13H20N2O2/c1-16-13-10-11(14)4-5-12(13)17-9-8-15-6-2-3-7-15/h4-5,10H,2-3,6-9,14H2,1H3
394248-90-9Relevant articles and documents
ISOQUINOLINONE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER
-
, (2016/03/19)
The present invention relates to a compound of the following formula (I) or a pharmaceutically acceptable salt and/or solvate thereof, notably for use as a drug, notably in the treatment of cancer, as well as pharmaceutical compositions containing such a
NOVEL AMINOALCOHOL-SUBSTITUTED ARYLDIHYDROISOQUINOLINONES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS
-
Page/Page column 87, (2008/06/13)
The invention relates to aminoalcohol-substituted aryldihydroisoquinolinones and their derivatives, and their physiologically tolerated salts and physiologically functional derivatives, their preparation, medicaments comprising at least one aminoalcohol-substituted aryldihydroisoquinolinone of the invention or its derivative, and the use of the aminoalcohol- substituted aryldihydroisoquinolinones of the invention and their derivatives as MCH antagonists.
NOVEL MCH RECEPTOR ANTAGONISTS
-
Page/Page column 27, (2008/06/13)
The present invention relates to a melanin concentrating hormone antagonist compound of formula (I): wherein R1, Ra, Rb, R2, L1, R3, R4 and R5 are as defined, or a pharmaceutically acceptable salt, enantiomer, diastereomer or mixture of diasteromers thereof useful in the treatment, obesity and related diseases.